Ornithine aminotransferase
Ornithine aminotransferase catalyses the conversion of L-ornithine and a 2-oxo acid to L-glutamate 5-semialdehyde and an L-amino acid. This enzyme is found in low-GC bacteria, where it is responsible for the fourth step in arginine biosynthesis, and in the mitochondrial matrix of eukaryotes, where it controls L-ornithine levels in tissues. In human hereditary ornithine aminotransferase deficiency, the elevated levels of intraocular concentrations of ornithine are responsible for gyrate atrophy, which affects the CNS and peripheral nervous system [PMID:12221166].
Reference Protein and Structure
- Sequence
-
P04181
(2.6.1.13)
(Sequence Homologues)
(PDB Homologues)
- Biological species
-
Homo sapiens (Human)

- PDB
-
2oat
- ORNITHINE AMINOTRANSFERASE COMPLEXED WITH 5-FLUOROMETHYLORNITHINE
(1.95 Å)
- Catalytic CATH Domains
-
3.40.640.10
(see all for 2oat)
- Cofactors
- Pyridoxal 5'-phosphate(2-) (1)
Enzyme Reaction (EC:2.6.1.13)
Enzyme Mechanism
Introduction
This PLP-dependent reaction proceeds via a ping-pong mechanism that requires two half-reactions to complete one cycle of transamination. In the first half-reaction the catalytic lysine is displaced from the PLP-cofactor by the ornithine substrate. This substrate is then deamminated to form the L-glutamate-gamma-semialdehyde. In the second half-reaction, the 2-oxoglutarate enters the active site and attacks the amminated PLP cofactor. The final glutamate product is then displaced from PLP to re-form the active site.
Catalytic Residues Roles
| UniProt | PDB* (2oat) | ||
| Asp263 | Asp263A | This residue helps stabilise the nitrogen atom of the PLP ring during catalysis, enabling the cofactor to act as an electron sink during the course of the reaction. | electrostatic stabiliser |
| Phe177 | Phe177A | This residue is important for maintaining the correct orientation of the cofactor in the active site when it is no longer attached to the protein. | steric role |
| Lys292 | Lys292A | This is the primary catalytic residue. It starts the reaction covalently attached to the PLP cofactor. It then acts as a general acid/base. In the final steps of the reaction it re-attaches to the PLP cofactor to regenerate the active site. | covalent catalysis, proton shuttle (general acid/base) |
Chemical Components
References
- Storici P et al. (1999), J Mol Biol, 285, 297-309. Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine1. DOI:10.1006/jmbi.1998.2289. PMID:9878407.
- Lee H et al. (2015), Med Res Rev, 35, 286-305. Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs. DOI:10.1002/med.21328. PMID:25145640.
- Markova M et al. (2005), J Biol Chem, 280, 36409-36416. Determinants of substrate specificity in omega-aminotransferases. DOI:10.1074/jbc.M506977200. PMID:16096275.
- Peltola KE et al. (2002), Neurology, 59, 735-740. Peripheral nervous system in gyrate atrophy of the choroid and retina with hyperornithinemia. PMID:12221166.
- Shen BW et al. (1998), J Mol Biol, 277, 81-102. Crystal structure of human recombinant ornithine aminotransferase. DOI:10.1006/jmbi.1997.1583. PMID:9514741.
- Shah SA et al. (1997), Structure, 5, 1067-1075. Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition. PMID:9309222.
Catalytic Residues Roles
| Residue | Roles |
|---|---|
| Asp263A | electrostatic stabiliser |
| Phe177A | steric role |
| Lys292A | proton shuttle (general acid/base), covalent catalysis |